Malaria antigens and methods of use

    公开(公告)号:US10780153B2

    公开(公告)日:2020-09-22

    申请号:US16393035

    申请日:2019-04-24

    申请人: GenVec, Inc.

    IPC分类号: A61K39/015 A61K39/00

    摘要: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.

    Malaria antigens and methods of use

    公开(公告)号:US10022432B2

    公开(公告)日:2018-07-17

    申请号:US15800975

    申请日:2017-11-01

    申请人: GenVec, Inc.

    IPC分类号: A61K39/015 A61K39/00

    摘要: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.

    MALARIA ANTIGENS AND METHODS OF USE
    4.
    发明申请
    MALARIA ANTIGENS AND METHODS OF USE 有权
    MALARIA抗原和使用方法

    公开(公告)号:US20150297699A1

    公开(公告)日:2015-10-22

    申请号:US14441988

    申请日:2013-11-12

    申请人: GENVEC, INC.

    IPC分类号: A61K39/015

    摘要: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.

    摘要翻译: 本发明涉及包含一种或多种多肽或一种或多种可诱导针对感染人的疟原虫物种的保护性免疫应答的核酸序列的组合物。 本发明还涉及使用这样的组合物来诱导针对哺乳动物的疟原虫寄生虫的保护性免疫应答的方法。

    Malaria antigens and methods of use

    公开(公告)号:US10314901B2

    公开(公告)日:2019-06-11

    申请号:US16008852

    申请日:2018-06-14

    申请人: GenVec, Inc.

    IPC分类号: A61K39/00 A61K39/015

    摘要: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.